Kimia Bioscien, a company in the Pharmaceuticals industry, reported revenue of ₹27 crore and net profit of ₹2.39 crore for the September 2026 quarter.
Kimia Bioscien. (BSE: KIMIABL) closed at ₹30.41 on 20 Nov 2026, down 10.8% over the past year. Its market capitalisation is ₹144 crore and it trades at 16.8 times earnings.
Incorporated in 1993, Kimia Biosciences Ltd is in the business of manufacturing and sale pharmaceutical products
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.